Baker Botts announced that Maureen Ohlhausen has joined the firm, and will become a partner and a Co-Chair of the global Antitrust Practice effective January 1, 2019.
From January 2017 to May 2018, Ms. Ohlhausen was Acting Chair of the Federal Trade Commission (FTC), the highest-ranking position in the agency, charged with antitrust enforcement and consumer protection. She served as FTC Commissioner from 2012 until her appointment as acting Chairman. She also led the FTC’s Office of Policy Planning, as its Director, from 2004-2008 before leaving the agency in 2008 to serve clients in private practice.
During her distinguished tenure at the top echelon of the FTC, Ms. Ohlhausen was a leading voice in shaping the current standards that apply to antitrust, privacy, and consumer protection laws, both in the US and globally through her interactions with regulators, elected officials, judges, and scholars, both at home and abroad. She has received numerous awards, including the FTC’s Robert Pitofsky Lifetime Achievement Award and the George Mason University Distinguished Alumni Award.
In early 2018, Ms. Ohlhausen was nominated by President Trump to serve on the United States Court of Federal Claims. She recently withdrew her nomination in favor of her decision to serve the needs of clients in private practice.
“Maureen has an exceptionally impressive background highlighted by her significant and influential recent tenure as Acting Chairman of the Federal Trade Commission and as a former Commissioner at the Federal Trade Commission. Our clients will directly benefit from having a lawyer with Maureen’s depth of experience available to work with them on their antitrust and FTC related matters,” said Andrew M. Baker, Managing Partner of Baker Botts.
Full Content: Baker Botts
Featured News
EU Regulators Probe SES-Intelsat Deal, Seek Insight on Starlink’s Competitive Threat
May 12, 2025 by
CPI
Trump Removes Copyright and Library of Congress Leaders After AI Policy Rift
May 12, 2025 by
CPI
Delta, Korean Air Buy Into WestJet in Major Cross-Border Deal
May 12, 2025 by
CPI
Trump Targets Big Pharma With Tough New Drug Pricing Rules
May 12, 2025 by
CPI
Geradin Partners Expands London Team with New Partner Hire
May 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece